Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...
Most companies don't survive for decades, much less pay regular dividends for that long. Healthcare leaders Merck (NYSE: MRK) ...
As a competitive powerlifter, Nathan Zenero has a unique talent for lifting heavy things. He’s also taken on more than a few challenges in his life, including sports injuries and thyroid cancer.
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...
Alors que François Bayrou a annoncé samedi 1er février qu'il allait déclenché l'article 49.3 pour obtenir la promulgatoi de ...
En tête de notre sélection cette semaine, l’économiste historien Arnaud Orain analyse le « capitalisme de la finitude » et ses mécanismes à trois époques, dont la nôtre. Et nous offre un diagnostic qu ...
La majorité des députés et les sénateurs de la commission mixte paritaire se sont entendus sur un projet de budget de l’Etat. Il doit être soumis à l’Assemblée lundi, avec l’utilisation probable du 49 ...
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Invité d’« À l’air libre », il évoque l’ampleur du narcotrafic ... Ruggia pour agressions sexuelles sur mineure lundi 3 février, la comédienne Adèle Haenel accorde sa première ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback